Anika Therapeutics Inc (ANIK)-Product Pipeline Analysis, 2017 Update

Anika Therapeutics Inc (ANIK)-Product Pipeline Analysis, 2017 Update

  • Products Id :- GDME791PD
  • |
  • Pages: 49
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Anika Therapeutics Inc (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers its products through distributors in the Americas, Europe, the Middle East, and Asia. Anika is headquartered in Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Anika Therapeutics Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Anika Therapeutics Inc Company Overview 6

Anika Therapeutics Inc Company Snapshot 6

Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Anika Therapeutics Inc-Pipeline Analysis Overview 9

Business Description 9

Anika Therapeutics Inc-Key Facts 9

Anika Therapeutics Inc-Major Products and Services 11

Anika Therapeutics Inc Pipeline Products by Development Stage 13

Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 15

Anika Therapeutics Inc Pipeline Products Overview 17

Cingal 17

Cingal Product Overview 17

Cronofill 18

Cronofill Product Overview 18

Hemostatic Patch 19

Hemostatic Patch Product Overview 19

HYAFF Barrier Film 20

HYAFF Barrier Film Product Overview 20

HYAFF Gel 21

HYAFF Gel Product Overview 21

HYAFF Mesh 22

HYAFF Mesh Product Overview 22

HYAFF/ACP Spray-Adhesion 23

HYAFF/ACP Spray-Adhesion Product Overview 23

Hyalobone 24

Hyalobone Product Overview 24

Hyalofast 25

Hyalofast Product Overview 25

Hyalofast Clinical Trial 26

Hyaloglide 27

Hyaloglide Product Overview 27

Hyalograft C Autograft 28

Hyalograft C Autograft Product Overview 28

Hyalonect 29

Hyalonect Product Overview 29


MONOVISC Product Overview 30


MONOVISC-Hip Product Overview 31

MONOVISC-Hip Clinical Trial 32

Next Generation ELEVESS Dermal Filler 33

Next Generation ELEVESS Dermal Filler Product Overview 33


ORTHOVISC-T Product Overview 34

Anika Therapeutics Inc-Key Competitors 35

Anika Therapeutics Inc-Key Employees 36

Anika Therapeutics Inc-Key Employee Biographies 37

Anika Therapeutics Inc-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Recent Developments 39

Anika Therapeutics Inc, Recent Developments 39

Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011 39

Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results 40

Dec 19, 2016: Anika Wins CE Mark Approval For ORTHOVISC-T To Relieve Pain and Restore Function of Tendons Damaged by Chronic Injury 41

Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 41

Sep 22, 2016: Anika Announces Data Presentations on HYALOFAST Hyaluronic Acid-Based Scaffold at 2016 World Congress of the International Cartilage Repair Society 42

Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results 42

Jun 01, 2016: Anika Announces European Commercial Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis 43

May 19, 2016: Pendopharm Announces Canadian Launch Of Cingal In Partnership With Anika Therapeutics 43

Apr 27, 2016: Anika Reports First Quarter 2016 Financial Results 44

Apr 04, 2016: Anika Appoints New Chief Medical Officer and Chief Operations Officer 45

Appendix 46

Methodology 46

About GlobalData 48

Contact Us 48

Disclaimer 48

List of Figures

Anika Therapeutics Inc Pipeline Products by Equipment Type 7

Anika Therapeutics Inc Pipeline Products by Development Stage 13

Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 15

List of Tables

Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Anika Therapeutics Inc Pipeline Products by Equipment Type 7

Anika Therapeutics Inc Pipeline Products by Indication 8

Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 8

Anika Therapeutics Inc, Key Facts 9

Anika Therapeutics Inc, Major Products and Services 11

Anika Therapeutics Inc Number of Pipeline Products by Development Stage 13

Anika Therapeutics Inc Pipeline Products Summary by Development Stage 14

Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 15

Anika Therapeutics Inc Ongoing Clinical Trials Summary 16

Cingal-Product Status 17

Cingal-Product Description 17

Cronofill-Product Status 18

Cronofill-Product Description 18

Hemostatic Patch-Product Status 19

Hemostatic Patch-Product Description 19

HYAFF Barrier Film-Product Status 20

HYAFF Barrier Film-Product Description 20

HYAFF Gel-Product Status 21

HYAFF Gel-Product Description 21

HYAFF Mesh-Product Status 22

HYAFF Mesh-Product Description 22

HYAFF/ACP Spray-Adhesion-Product Status 23

HYAFF/ACP Spray-Adhesion-Product Description 23

Hyalobone-Product Status 24

Hyalobone-Product Description 24

Hyalofast-Product Status 25

Hyalofast-Product Description 25

Hyalofast-A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast with BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control 26

Hyaloglide-Product Status 27

Hyaloglide-Product Description 27

Hyalograft C Autograft-Product Status 28

Hyalograft C Autograft-Product Description 28

Hyalonect-Product Status 29

Hyalonect-Product Description 29

MONOVISC-Product Status 30

MONOVISC-Product Description 30

MONOVISC-Hip-Product Status 31

MONOVISC-Hip-Product Description 31

MONOVISC-Hip-Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip 32

Next Generation ELEVESS Dermal Filler-Product Status 33

Next Generation ELEVESS Dermal Filler-Product Description 33

ORTHOVISC-T-Product Status 34

ORTHOVISC-T-Product Description 34

Anika Therapeutics Inc, Key Employees 36

Anika Therapeutics Inc, Key Employee Biographies 37

Anika Therapeutics Inc, Subsidiaries 38

Glossary 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Repligen Corp, Momenta Pharmaceuticals Inc, MiMedx Group Inc, MacroGenics Inc, Corium International Inc, Aegerion Pharmaceuticals Inc

select a license

Single User License
USD 750 INR 50588
Site License
USD 1500 INR 101175
Corporate User License
USD 2250 INR 151763



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]